President Obama kommer till Europa för att tala på Nordic Business Forum
President Obama kommer att resa till Europa för att delta på Nordic Business Forum i Helsingfors den 26–27 september 2018. Obama kommer att tala till en av de största publikerna i Norden och avrunda tvådagarskonferensen med den avslutande konversationen.
Detta pressmeddelande använder multimedia. Se den fullständiga versionen här: https://www.businesswire.com/news/home/20180621005424/sv/
Europe’s leading business and leadership conference brings President Obama to Helsinki, Finland to speak to business executives and owners. (Photo: Business Wire)
Aslak de Silva, VD för Nordic Business Forum: ”Vi är utan tvekan ärade att få vara värd för Obama - men detta ögonblick tillhör verkligen vår publik och Norden som helhet. Det kommer att bli oförglömligt. "
Ville Saarikalle, ansvarig för Speaker Relations på Nordic Business Forum: "President Obama är en av de mest anmärkningsvärda ledarna för sin tid. Hans livsresa är unik: från blygsamma förhållanden till president i USA. Det är verkligen en ära att ha honom på Nordic Business Forum i september."
2018-utgåvan av det Nordic Business Forum kommer att fokusera på Strategy, Peak Performance, och Artificial Intelligence. Tidigare tillkännagivna talare innefattar Whole Food Markets grundare och VD John Mackey, OS-guldmedaljören Lindsey Vonn, Strategos grundare Gary Hamel, socialpsykologen Amy Cuddy, mediateoretikern Don Tapscott, Medgrundare till MIT-initativet Digital Economy Andrew McAfee och Quiet Revolutions medgrundare Susan Cain.
Nordic Business Forum är mer än en affärskonferens. Utöver flaggskeppeventet i Helsingfors har företaget expanderat till andra nordiska länder och arrangerar för närvarande event i Finland, Sverige, Norge och Danmark. Konferenserna är känd för att sammanföra världens främsta experter och ledare
Företagets mål är att bygga ledare som förändrar världen. Detta gör de genom att inspirera och utrusta företagsledare med idéer och nätverk som hjälper dem att bli bättre ledare, få företagen att växa och göra världen till en bättre plats.
Tidigare talare på Nordic Business Forum inkluderar vicepresident Al Gore, Jack Welch, Arnold Schwarzenegger, Arianna Huffington, Sir Richard Branson, Ben Bernanke, Will Smith, Steve Wozniak och många fler.
Information online:
Eventwebbplats: www.nbforum.com/nbf2018
President Obamas bio: www.nbforum.com/nbf2018/speakers/barack-obama/
NBForum 2017 Aftermovie: https://youtu.be/Rd_4E6T5brM
Fler evenemangssamlingar tillgängliga på www.nbforum.com/tag/nbforum-event-compilations/
Foton:
Nordic Business Forum 2017 i Helsingfors
Fler bilder finns på www.nbforum.com/company
Sociala medier:
Twitter: @NBForumHQ, # NBForum2018
Facebook: www.facebook.com/nbforumhq & https://www.facebook.com/events/144545802818126
Media ackrediteringar:
Evenemanget är öppet för att trycka. Vänligen fyll i ackrediteringsformuläret för att begära ett presspass på evenemanget på www.nbforum.com/company/#media
Nordic Business Forum är Europas ledande konferensarrangör med evenemang i Finland, Sverige, Norge och Danmark. Det årliga flaggskeppeventet i Helsingfors lockar 7500 företagsledare och företagare från över 40 nationaliteter och når över 20,000 människor över hela världen via live stream. Tidigare talare inkluderar Al Gore, Jack Welch, Arnold Schwarzenegger, Arianna Huffington, Sir Richard Branson, Ben Bernanke, Will Smith, Steve Wozniak, och många andra. För mer information, besök www.nbforum.com .
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
Se källversionen på businesswire.com: https://www.businesswire.com/news/home/20180621005424/sv/
Contact information
Nordic Business Forum
Anniina Turunen
Chef för
marknadsföring och kommunikation
+358-50-563-6025
anniina.turunen@nbforum.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Meiji Seika Pharma Partners With MBC BioLabs to Strengthen Global Innovation in Drug Discovery19.12.2025 02:00:00 CET | Press Release
Meiji Seika Pharma Co., Ltd. (Headquarters: Chuo-ku, Tokyo; President & CEO: Toshiaki Nagasato) today announced that it has entered into a partnership agreement with MBC BioLabs which is a private organization supporting the development of biotech startup companies in California’s San Francisco Bay Area. MBC BioLabs provides fully equipped research facilities and a supportive community that help biotech entrepreneurs accelerate from concept to company. By removing the burden of building and maintaining laboratory infrastructure, resident companies can focus early on research and development while efficiently advancing commercialization. Through this partnership, Meiji Seika Pharma will further advance its open-innovation initiatives and strengthen research and development in its priority therapeutic areas: infectious diseases, hematologic diseases, and immune-inflammatory diseases. By engaging with the entrepreneurs and startup community at MBC BioLabs, the company aims to discover inn
Enry's Island SpA Strengthens Its Leadership in Venture Capital with Explosive Growth and Redesigns the Future of VC Through Gaming19.12.2025 00:34:00 CET | Press Release
Enry’s Island SpA (WBAG:EIOS), the world’s first publicly listed venture builder, announces a new era of growth, innovation, and the democratization of Venture Capital (VC). The company has delivered exceptional results, consolidating its position as an industry leader through a strategic positioning in the rapidly expanding gaming market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218742236/en/ Record Growth and Performance Enry’s Island SpA has demonstrated an extraordinary growth trajectory and a strong financial and operational track record: Revenues: +250% year-over-year (YoY). Exit: $3.6M in exits realized via IPO. Portfolio: 1 IPO of a portfolio company completed in December 2024, with an additional 2 IPOs expected in 2026. The performance of the EIOS:VSE stock reflects this strength: Price per Share (PPS): +132% in the first half (H1) of 2025, stabilizing at a +116% YTD increase. Daily Trading Volume: peaks of
500 Global Expands Africa Presence; Selected to Advance Digital Morocco 2030 Strategy18.12.2025 21:37:00 CET | Press Release
500 Global, one of the world’s most active venture capital firms1, announced it has been selected to support the Ministry-led Startup VB initiative, a flagship program under the Digital Morocco 2030 strategy2. This announcement marks a significant milestone in 500 Global’s continued expansion across the African continent and its work collaborating with governments to strengthen national innovation ecosystems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218363323/en/ Announcement of 500 Global's continued expansion across Africa and support of Digital Morocco 2030 Launched by the Ministry of Digital Transition and Administrative Reform (Ministry) and deployed by TAMWILCOM, the Startup VB initiative is a flagship program under the Digital Morocco 2030 strategy. Startup VB aims to strengthen Morocco’s innovation and digital competitiveness by accelerating high-potential founders and providing the training and financing pa
Neural Concept Closes $100M Funding Round Led by Growth Equity at Goldman Sachs Alternatives to Scale AI-Native Engineering18.12.2025 17:00:00 CET | Press Release
Neural Concept, a global AI platform and leader in Engineering Intelligence powering next-generation product development, today announced it raised a $100 million Series C funding round led by Growth Equity at Goldman Sachs Alternatives, with existing investors Forestay Capital, Alven, HTGF, D.E. Shaw Ventures and Aster Capital. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218764112/en/ Image courtesy of Neural Concept (L-R clockwise from top) Jonathan Donier, CSO & Co-founder; Thomas von Tschammer, Managing Director US & Co-founder; Théophile Allard, CTO & Co-founder; Pierre Baqué CEO & Co-founder; Philippe Cuendet, COO Neural Concept is redefining engineering workflows with CAD-native enterprise AI that understands geometry, constraints and design intent. By helping its customers build and deploy physics-aware design copilots, the platform enables teams to explore millions of design options earlier and avoid costly la
Croma-Pharma Introduces New Medical Device for the Preparation of Autologous PRP | Fluid- PRF18.12.2025 16:57:00 CET | Press Release
Croma-Pharma, a global player in minimally invasive aesthetic medicine, proudly announces the launch of its new medical device that is used for the preparation of autologous Platelet-Rich Plasma (PRP) | Fluid-Platelet-Rich Fibrin (Fluid-PRF).1 This launch represents continued progress in Croma’s mission to provide healthcare professionals state-of-the-art tools for their practice. With its innovative design and optimized separation technology, Exprecell™ enables the efficient preparation of autologous blood concentrates, without the use of anticoagulants, resulting in the formation of Fluid-PRF, a biologically active concentrate that retains the regenerative properties of platelets and leukocytes, yet stays liquid for a defined period.1 What makes Exprecell™ special? MDR certification: Exprecell™ is MDR-certified, meeting stringent EU regulatory requirements to ensure the safe, controlled and standardized preparation of autologous Platelet-Rich Plasma (PRP) | Fluid-Platelet-Rich Fibrin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom